Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Embeda in Chronic Pain
NCT00415597Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Embeda in chronic pain, sponsored by Pfizer. Primary endpoint: Treatment Emergent Adverse Events at 12 months. Started Dec 2006; status: completed.
02
Drugs
Embeda
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00415597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415597.